Martin Capital Partners, LLC Pfizer Inc Transaction History

Martin Capital Partners, LLC

$84.3 Million
Q4 2024

A detailed history of Martin Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Martin Capital Partners, LLC holds 54,678 shares of PFE stock, worth $1.45 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares

54,678

Previous 136,686 60.0%

Holding current value

$1.45 Million

Previous $3.96 Million 63.32%

% of portfolio

1.72%

Previous 1.95%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$24.8 - $30.19 $2.03 Million - $2.48 Million	-82,008 Reduced 60.0%	54,678 $1.45 Million
Q3 2024 Oct 15, 2024	SELL	$27.7 - $31.39 $1.23 Million - $1.39 Million	-44,438 Reduced 24.53%	136,686 $3.96 Million
Q2 2024 Jul 15, 2024	BUY	$25.26 - $29.6 $21,294 - $24,952	843 Added 0.47%	181,124 $5.07 Million
Q1 2024 Apr 05, 2024	BUY	$25.89 - $29.73 $2.5 Million - $2.87 Million	96,699 Added 115.69%	180,281 $5 Million
Q4 2023 Jan 05, 2024	SELL	$26.13 - $33.94 $493,647 - $641,194	-18,892 Reduced 18.44%	83,582 $2.41 Million
Q3 2023 Oct 13, 2023	BUY	$32.09 - $37.51 $95,146 - $111,217	2,965 Added 2.98%	102,474 $3.4 Million
Q2 2023 Jul 17, 2023	SELL	$36.12 - $41.79 $26,006 - $30,088	-720 Reduced 0.72%	99,509 $3.65 Million
Q1 2023 Apr 05, 2023	SELL	$39.39 - $51.28 $2.57 Million - $3.35 Million	-65,251 Reduced 39.43%	100,229 $4.09 Million
Q4 2022 Jan 05, 2023	SELL	$41.75 - $54.5 $477,494 - $623,316	-11,437 Reduced 6.46%	165,480 $8.48 Million
Q3 2022 Oct 06, 2022	BUY	$43.76 - $53.42 $1.58 Million - $1.93 Million	36,218 Added 25.74%	176,917 $7.74 Million
Q2 2022 Jul 08, 2022	BUY	$46.53 - $55.17 $315,845 - $374,493	6,788 Added 5.07%	140,699 $7.38 Million
Q1 2022 Apr 06, 2022	SELL	$45.75 - $56.69 $2.29 Million - $2.84 Million	-50,070 Reduced 27.21%	133,911 $6.93 Million
Q4 2021 Jan 07, 2022	BUY	$41.32 - $61.25 $12,272 - $18,191	297 Added 0.16%	183,981 $10.9 Million
Q3 2021 Oct 06, 2021	BUY	$39.25 - $50.42 $171,758 - $220,637	4,376 Added 2.44%	183,684 $7.9 Million
Q2 2021 Jul 06, 2021	BUY	$35.91 - $40.68 $73,615 - $83,394	2,050 Added 1.16%	179,308 $7.02 Million
Q1 2021 Apr 14, 2021	BUY	$33.49 - $37.77 $261,690 - $295,134	7,814 Added 4.61%	177,258 $6.42 Million
Q4 2020 Jan 07, 2021	SELL	$33.47 - $42.56 $79,424 - $100,994	-2,373 Reduced 1.38%	169,444 $6.24 Million
Q3 2020 Oct 08, 2020	SELL	$31.75 - $37.25 $113,474 - $133,131	-3,574 Reduced 2.04%	171,817 $6.31 Million
Q2 2020 Jul 07, 2020	SELL	$30.12 - $36.54 $83,673 - $101,508	-2,778 Reduced 1.56%	175,391 $5.74 Million
Q1 2020 Apr 21, 2020	SELL	$27.03 - $38.62 $125,959 - $179,969	-4,660 Reduced 2.55%	178,169 $5.82 Million
Q4 2019 Jan 31, 2020	BUY	$32.92 - $37.36 $348,984 - $396,053	10,601 Added 6.16%	182,829 $7.16 Million
Q3 2019 Nov 20, 2019	BUY	$32.49 - $42.13 $935,127 - $1.21 Million	28,782 Added 20.06%	172,228 $6.19 Million
Q2 2019 Aug 12, 2019	BUY	$36.98 - $41.52 $215,593 - $242,061	5,830 Added 4.24%	143,446 $6.21 Million
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $586,125 - $643,956	15,630 Added 12.81%	137,616 $5.85 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $197,235 - $224,870	5,127 Added 4.39%	121,986 $5.33 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $91,724 - $111,256	2,661 Added 2.33%	116,859 $5.15 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $189,898 - $202,451	-5,758 Reduced 4.8%	114,198 $4.14 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $109,578 - $127,126	3,434 Added 2.95%	119,956 $4.26 Million
Q4 2017 Feb 13, 2018	BUY	$33.26 - $35.29 $3.88 Million - $4.11 Million	116,522	116,522 $4.22 Million

Others Institutions Holding PFE

# of Institutions

3,228

Shares Held

3.62B

Call Options Held

77.1M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Martin Capital Partners, LLC with notifications on news.

Account

Martin Capital Partners, LLC Pfizer Inc Transaction History